UBN-2 Activators
UBN-2 activators encompass a diverse group of chemicals that indirectly modulate the chromatin landscape, thus influencing the function of UBN-2 in histone chaperoning and incorporation into chromatin. These activators work through a variety of mechanisms, such as the inhibition of DNA methyltransferases, histone deacetylases (HDACs), and histone methyltransferases, or by affecting the ATM/ATR-mediated DNA damage response. By doing so, they alter the epigenetic marks that guide the assembly and remodeling of chromatin, creating a scenario where the function of UBN-2 is either necessitated or enhanced to maintain genomic stability and facilitate gene expression. The alterations in histone modification patterns, DNA methylation landscapes, and chromatin architecture as a result of these chemical interactions can, therefore, establish a context in which UBN-2's activity in histone exchange and deposition becomes critical.
The collective activity of these compounds reveals an interconnectedness of epigenetic regulation and chromatin dynamics. The activity of UBN-2 is tied to the structural and functional state of chromatin, which is constantly being modulated by a plethora of signaling pathways and environmental cues. By influencing these pathways, the identified chemicals set the stage for UBN-2 to engage in its biological role. Given the complexity of chromatin-related processes, the chemicals that act as indirect activators of UBN-2 can elicit a range of cellular responses that necessitate the precise action of histone chaperones, among which UBN-2 plays a pivotal part.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor that promotes histone acetylation, potentially enhancing chromatin accessibility and thereby facilitating UBN-2 mediated histone exchange. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
DNA methyltransferase inhibitor that does not incorporate into DNA. It can induce chromatin remodeling, potentially increasing UBN-2 activity indirectly by requiring histone H3.3 incorporation. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
Inhibitor of G9a histone methyltransferase, leading to reduced H3K9 methylation, a mark for heterochromatin, which could create a requirement for UBN-2 mediated histone H3.3 incorporation into areas of chromatin undergoing transcriptional activation. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
Potent G9a and GLP histone methyltransferase inhibitor, similar to BIX-01294, it can enhance chromatin dynamics requiring histone chaperone activity potentially involving UBN-2. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
At high concentrations, caffeine can inhibit ATM and ATR kinase activities, potentially impacting DNA repair pathways and thus influencing the histone deposition activity of UBN-2 indirectly. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Sirtuin inhibitor, it may lead to increased acetylation of proteins involved in chromatin remodeling, potentially influencing UBN-2's role in histone deposition. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
HDAC inhibitor that can cause hyperacetylation of histones, potentially altering chromatin architecture and increasing the demand for UBN-2 function in histone H3.3 deposition. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $124.00 $502.00 | 13 | |
Inhibitor of histone acetyltransferases (HATs), altering the acetylation status of histones and other proteins, potentially affecting UBN-2 mediated histone exchange. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
BET bromodomain inhibitor, affects the reading of acetylation marks, potentially altering chromatin organization and impacting the role of UBN-2 in histone deposition processes. | ||||||